Open access · OA
via OpenAlex
Early Parkinson's disease symptoms in -synuclein transgenic monkeys
Yuyu Niu, Xiangyu Guo, Y. Chen, Chuan-En Wang, J. Gao, W. Yang, Y. Kang, Wei Si, H. Wang, Shang‐Hsun Yang, S. Li, Weizhi Ji, Xing Li
Human Molecular Genetics · 2014 · ▲ 105 citations
Abstract
Parkinson's disease (PD) is an age-dependent neurodegenerative disease that can be caused by genetic mutations in α-synuclein (α-syn) or duplication of wild-type α-syn; PD is characterized by the deposition of α-syn aggregates, indicating a gain of toxicity from accumulation of α-syn. Although the major neuropathologic feature of PD is the degeneration of dopaminergic (DA) neurons in the substantia nigra, non-motor symptoms including anxiety, cognitive defect and sleep disorder precede the onset of motor impairment, and many clinical symptoms of PD are not caused by degeneration of DA neurons. Non-human primate models of PD are important for revealing the early pathology in PD and identifying effective treatments. We established transgenic PD rhesus monkeys that express mutant α-syn (A53T). Six transgenic A53T monkeys were produced via lentiviral vector expressing A53T in fertilized monkey eggs and subsequent embryo transfer to surrogates. Transgenic A53T is expressed in the monkey brain and causes age-dependent non-motor symptoms, including cognitive defects and anxiety phenotype, without detectable sleeping disorders. The transgenic α-syn monkeys demonstrate the specific early symptoms caused by mutant α-syn and provide insight into treatment of early PD.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1093/hmg/ddu748
- Canonical
- link ↗
- Fetched
- 2026-10-20 MST
Cite this
APA
Niu, Y., Guo, X., Chen, Y., Wang, C., Gao, J., Yang, W., Kang, Y., Si, W., Wang, H., Yang, S., Li, S., Ji, W., & Li, X. (2014). Early Parkinson's disease symptoms in -synuclein transgenic monkeys. <em>Human Molecular Genetics</em>. https://doi.org/10.1093/hmg/ddu748
Vancouver
Niu Y, Guo X, Chen Y, Wang C, Gao J, Yang W, et al. Early Parkinson's disease symptoms in -synuclein transgenic monkeys. Human Molecular Genetics. 2014. doi:10.1093/hmg/ddu748.
BibTeX
@article{yuyu2014EarlyP,
title = {Early Parkinson's disease symptoms in -synuclein transgenic monkeys},
author = {Yuyu Niu and Xiangyu Guo and Y. Chen and Chuan-En Wang and J. Gao and W. Yang and Y. Kang and Wei Si and H. Wang and Shang‐Hsun Yang and S. Li and Weizhi Ji and Xing Li},
journal = {Human Molecular Genetics},
year = {2014},
doi = {10.1093/hmg/ddu748},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
PLoS ONE 2012
Open access · CC-BY
The Role of Alpha-Synuclein Oligomerization and Aggregation in Cellular and Animal Models of Parkinson’s Disease
Biomedicine & Pharmacotherapy 2019
Open access · CC-BY
Progress of immunotherapy of anti-α-synuclein in Parkinson’s disease
Journal of Neuroscience 2004
Open access · CC-BY
Early and Progressive Sensorimotor Anomalies in Mice Overexpressing Wild-Type Human α-Synuclein
Behavioural Brain Research 2017
Open access · CC-BY
Alpha-Synuclein transgenic mice, h-α-SynL62, display α-Syn aggregation and a dopaminergic phenotype reminiscent of Parkinson’s disease
Journal of Neurochemistry 2024
Open access · CC-BY
The role of age‐associated alpha‐synuclein aggregation in a conditional transgenic mouse model of Parkinson's disease: Implications for Lewy body formation
Seven Editora eBooks 2024
Open access · CC-BY